Synthetic molecular sensors based on CRISPR-Cas9 redirect anticancer signal flows to treat retinoblastomas.

ABSTRACT:

SUBMITTER: Xiao L 

PROVIDER: S-EPMC8574887 | biostudies-literature | 2021 Nov

REPOSITORIES: biostudies-literature